Greg Mann

Greg Mann is a highly accomplished professional with a rich educational background in BA from Wesleyan University and M.A., C.Phil., Science Studies from UC San Diego.

During his career, Greg has held several notable positions in the corporate world, showcasing his expertise in strategy, corporate affairs, public affairs, investor relations, and corporate communications.

He has previously served as the Senior Vice President of Strategy & Corporate Affairs as well as the Senior Vice President of Public Affairs & Investor Relations at Nkarta, Inc.

Greg has also held Vice President roles in investor relations at Gilead Sciences, Kite Pharma, Inc., and a range of other pharmaceutical companies, demonstrating his extensive experience in this field.

His tenure includes leadership positions in communication and investor relations at various key organizations such as FibroGen, Transcept Pharmaceuticals, Inc., BiPar Sciences, Inc., XOMA, Renovis, Abgenix, and Specialty Laboratories.

With his diverse background and wealth of experience in the pharmaceutical and biotech industry, Greg Mann is a seasoned professional adept at navigating the complex landscape of corporate communication and investor relations.